Cargando…

Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling

[Image: see text] Nanomaterials (NMs) have been increasingly used in a number of areas, including consumer products and nanomedicine. Target tissue dosimetry is important in the evaluation of safety, efficacy, and potential toxicity of NMs. Current evaluation of NM efficacy and safety involves the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhoumeng, Aryal, Santosh, Cheng, Yi-Hsien, Gesquiere, Andre J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798869/ https://www.ncbi.nlm.nih.gov/pubmed/36520546 http://dx.doi.org/10.1021/acsnano.2c07312

Ejemplares similares

Advanced computational modeling for in vitro nanomaterial dosimetry
por: DeLoid, Glen M., et al.
Publicado: (2015)

An integrated approach for the in vitro dosimetry of engineered nanomaterials
por: Cohen, Joel M, et al.
Publicado: (2014)

An in vitro assay and artificial intelligence approach to determine rate constants of nanomaterial-cell interactions
por: Price, Edward, et al.
Publicado: (2019)

Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats
por: Chou, Wei-Chun, et al.
Publicado: (2022)

Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach
por: Cheng, Yi-Hsien, et al.
Publicado: (2020)

Author Correction: An in vitro assay and artificial intelligence approach to determine rate constants of nanomaterial-cell interactions
por: Price, Edward, et al.
Publicado: (2019)

Animal simulations facilitate smart drug design through prediction of nanomaterial transport to individual tissue cells
por: Price, Edward, et al.
Publicado: (2020)

Estimating the effective density of engineered nanomaterials for in vitro dosimetry
por: DeLoid, Glen, et al.
Publicado: (2014)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
por: Utembe, Wells, et al.
Publicado: (2020)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
por: Kim, Min-Chang, et al.
Publicado: (2022)

Nanotoxicology: in Vitro–in Vivo Dosimetry
por: Oberdörster, Günter
Publicado: (2012)

Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values
por: Chou, Wei-Chun, et al.
Publicado: (2021)

Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part I: Cattle and swine
por: Lin, Zhoumeng, et al.
Publicado: (2020)

Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part II: Chicken and turkey
por: Wang, Yu‐Shin, et al.
Publicado: (2020)

Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling
por: Campbell, Jerry, et al.
Publicado: (2016)

An In Vitro Dosimetry Tool for the Numerical Transport Modeling of Engineered Nanomaterials Powered by the Enalos RiskGONE Cloud Platform
por: Cheimarios, Nikolaos, et al.
Publicado: (2022)

Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part III: Sheep and goat
por: Li, Miao, et al.
Publicado: (2020)

Reconstructing Organophosphorus Pesticide Doses Using the Reversed Dosimetry Approach in a Simple Physiologically-Based Pharmacokinetic Model
por: Lu, Chensheng, et al.
Publicado: (2012)

In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
por: Boraschi, Diana, et al.
Publicado: (2021)

Review of nanomaterial advances for ionizing radiation dosimetry
por: Aboelezz, Eslam, et al.
Publicado: (2023)

Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
por: Shi, Miaoying, et al.
Publicado: (2020)

Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
por: Yoon, Miyoung, et al.
Publicado: (2016)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
por: Murata, Yukiko, et al.
Publicado: (2022)

Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
por: Yamazaki, Shinji, et al.
Publicado: (2021)

Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data
por: Zhang, Mengying, et al.
Publicado: (2017)

Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
por: Yamazaki, Shinji, et al.
Publicado: (2022)

Use of Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Acute Toxicity of Tetrodotoxin in Rodents
por: Noorlander, Annelies, et al.
Publicado: (2022)

A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
por: Jones, Hannah M., et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
por: Zeng, Dongping, et al.
Publicado: (2018)

Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
por: Hines, David E., et al.
Publicado: (2022)

Integration of Physiologically-Based Pharmacokinetic Modeling into Early Clinical Development: An Investigation of the Pharmacokinetic Nonlinearity
por: Zhou, L, et al.
Publicado: (2015)

Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against Edwardsiella ictaluri in Yellow Catfish (Pelteobagrus fulvidraco)
por: Xu, Ning, et al.
Publicado: (2021)

A new pharmacokinetic model for (90)Y-ibritumomab tiuxetan based on 3-dimensional dosimetry
por: Morschhauser, F., et al.
Publicado: (2018)

In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs
por: Rojas Gómez, Ricardo, et al.
Publicado: (2015)

The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models
por: Herrera, Carolina
Publicado: (2019)

In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine
por: Chen, Feifei, et al.
Publicado: (2020)

Molecular Imaging, Pharmacokinetics, and Dosimetry of (111)In-AMBA in Human Prostate Tumor-Bearing Mice
por: Ho, Chung-Li, et al.
Publicado: (2011)

Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling
por: Schalkwijk, Stein, et al.
Publicado: (2017)

An Interactive Generic Physiologically Based Pharmacokinetic (igPBPK) Modeling Platform to Predict Drug Withdrawal Intervals in Cattle and Swine: A Case Study on Flunixin, Florfenicol, and Penicillin G
por: Chou, Wei-Chun, et al.
Publicado: (2022)

Combining In Vitro Data and Physiologically Based Kinetic Modeling Facilitates Reverse Dosimetry to Define In Vivo Dose–Response Curves for Bixin‐ and Crocetin‐Induced Activation of PPARγ in Humans
por: Suparmi, Suparmi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rol7bsg7o6qdi3jv62nbmmnivf